title: [Surgical procedure connected complications in women with cervical cancer operated with ovarian transposition (transpositio ovariorum)].
abstract: OBJECTIVE
  Approximately one-half of women with cervical cancer are premenopausal. Preservation of ovarian function in these women is highly desirable. The safety and efficacy of ovarian retention include risk of ovarian metastasis, risk of surgery, psychological impact of surgical castration, expense of hormone supplementation.
  
  
  METHODS
  This report compares intra- and postoperative surgical complications in 2 groups of women with cancer in stage Ib and IIa treated by radical hysterectomy (Wertheim-Meigs operation).
  
  
  METHODS
  Two groups were compared: 72 patients with ovarian transposition and 55 women without transposition, but after brachy-HDR therapy. The surgery time was mean 30 minute longer in case of ovarian transposition.
  
  
  RESULTS
  There was no difference in mean time of hospital stay after the surgery, the frequency of relaparotomy, deep vein thrombosis, urological complications and blood transfusion between the groups. There was confirmed the higher number of lymphatic pseudocysts (p < 0.0005) and fever (p < 0.001) in women without transposition, but after brachy-HDR therapy. We linked this with the previously applied radiotherapy.
  
  
  CONCLUSIONS
  We conclude that ovarian transposition is the procedure which can safe the endogenous ovarian function in young women with cervical cancer without the higher risk of complications.
authors.affiliation: I Katedry i Kliniki Połoznictwa i Ginekologii SIAM w Bytomiu.
authors.forename: A
authors.initials: A
authors.lastname: Olejek
authors.forename: J
authors.initials: J
authors.lastname: Rzempołuch
authors.forename: S
authors.initials: S
authors.lastname: Adamczyk
authors.forename: P
authors.initials: P
authors.lastname: Binkiewicz
authors.forename: P
authors.initials: P
authors.lastname: Chimiczewski
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010053:Ovary / Q000502:physiology* / Q000601:surgery*; D011183:Postoperative Complications / Q000175:diagnosis*; D012189:Retrospective Studies; D002583:Uterine Cervical Neoplasms / Q000601:surgery*